Abbreviations:
ADAMTS5, A disintegrin and metalloproteinase with thrombospondin motifs 5; APOC3, apolipoprotein C-III; AUC, area under the curve; BMI, body mass index; CD99, CD99 antigen; CE-MS, capillary electrophoresis coupled to mass spectrometry; COL1A1, collagen alpha-1(I) chain; COL1A2, collagen alpha-2(I) chain; COL3A1, collagen alpha-1(III) chain; CRNN, Cornulin; CPSF6, cleavage and polyadenylation specificity factor subunit 6; eGFR, estimated glomerular filtration rate; FDR, false discovery rates; GLP-1R, Glucagon-like peptide-1 receptor; HbA1C, Hemoglobin A1C; HBA, hemoglobin subunit alpha; KEGG, Kyoto Encyclopedia of Genes and Genomes; MB, myoglobin; MMP, matrix metalloproteinase proteases; PIGR, polymeric immunoglobulin receptor; PROVALID, Prospective Cohort Study in Patients with T2DM for Validation of Biomarkers study; SBP/DBP, systolic/diastolic blood pressure SERPINA1, alpha-1-antitrypsin; SERPINA6, corticosteroid-binding globulin; T2DM, Type II diabetes mellitus; TTR, transthyretin; VGF, neurosecretory protein VGF
Keywords: CE-MS, GLP-1R agonists, peptidomics, T2DM, urine biomarker